| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/21/2011 | CN102188432A Medicines for preventing and treating epilepsia |
| 09/21/2011 | CN102188420A Levetiracetam medicinal composition and preparation method thereof |
| 09/21/2011 | CN102188414A Application of dehydroeffusol in preparing medicament with anti-anxiety function |
| 09/21/2011 | CN102188412A Selegiline-containing adhesive preparation |
| 09/21/2011 | CN102188411A Selegiline-containing adhesive preparation |
| 09/21/2011 | CN102188410A Selegiline-containing adhesive preparation |
| 09/21/2011 | CN102188392A Stabilized divalproex sodium coated granules, preparation method and solid preparation thereof |
| 09/21/2011 | CN102188384A Microsphere preparation method for adjusting and controlling release behavior of risperidone microspheres and for controlling size thereof |
| 09/21/2011 | CN102188381A Preparation method of orexin-A medicament carrying liposome and medicament for treating paroxysmal sleep |
| 09/21/2011 | CN102188363A Transdermal medicament delivery system containing donepezil compound, preparation and preparation method |
| 09/21/2011 | CN102188134A Pillow with traditional Chinese medicines for treating neurasthenia |
| 09/21/2011 | CN102188130A Mixed pill pillow of traditional Chinese medicines and turmaline and preparation method thereof |
| 09/21/2011 | CN101979077B Traditional Chinese medicine for treating heart cerebrovascular diseases |
| 09/21/2011 | CN101904906B Rhizoma corydalis pain-relieving dripping pill preparation and preparation process thereof |
| 09/21/2011 | CN101856401B Externally-applied Chinese medical composition for treating insomnia |
| 09/21/2011 | CN101804190B Tongbi cream for relieving rigidity of muscles and promoting blood circulation and preparation method thereof |
| 09/21/2011 | CN101791336B Extract from long pepper and preparation method and application thereof |
| 09/21/2011 | CN101791302B Medicinal composition containing sodium ferulate and preparation method thereof |
| 09/21/2011 | CN101780176B Traditional Chinese medicine preparation for treating nervous headache |
| 09/21/2011 | CN101732646B Capsule for tonifying kidneys and nourishing brain |
| 09/21/2011 | CN101711752B Controlled release preparation of benzo-isoxazole derivant and preparation method thereof |
| 09/21/2011 | CN101700311B Method for producing lozenge capable of tonifying qi and soothing nerves |
| 09/21/2011 | CN101589046B Azaspiro derivatives |
| 09/21/2011 | CN101559195B Epilepsy therapy capsule and preparation method thereof |
| 09/21/2011 | CN101352491B Foot plaster medicament for treating trigeminal neuralgia |
| 09/21/2011 | CN101306079B Decoction for treating poliomyelitis |
| 09/21/2011 | CN101301430B Decoction for treating blood deficiency type neurasthenic |
| 09/21/2011 | CN101214253B Application of anemarrhenasaponin B-II in preparing antidepressant product |
| 09/21/2011 | CN101204524B Tincture medicine for migraine |
| 09/21/2011 | CN101129654B Orally taken traditional Chinese medicine for treating cerebral hemorrhage sequela |
| 09/21/2011 | CN101129621B Anti-alcoholic medical tea |
| 09/21/2011 | CN101084009B Gh secretagogues and uses thereof |
| 09/20/2011 | US8022250 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases |
| 09/20/2011 | US8022215 Fused pyridone M1 receptor positive allosteric modulators |
| 09/20/2011 | US8022176 FAS peptide mimetics and uses thereof |
| 09/20/2011 | US8022074 4-(phenyl-piperazinyl-methyl)benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 09/20/2011 | US8022065 Purine derivatives as kinase inhibitors |
| 09/20/2011 | US8022062 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists |
| 09/20/2011 | US8022058 Agents for preventing and treating disorders involving modulation of the RyR receptors |
| 09/20/2011 | US8022041 Prodrug of an ICE inhibitor |
| 09/20/2011 | US8021876 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
| 09/20/2011 | US8021838 Transcriptional regulation of target genes |
| 09/20/2011 | US8021693 Methods of organ regeneration using Hox11-expressing pluripotent cells |
| 09/20/2011 | US8021687 Modified release compositions of milnacipran |
| 09/20/2011 | US8021658 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 09/20/2011 | CA2657106C Aminoindane derivative or salt thereof |
| 09/20/2011 | CA2541458C Pyrrole and pyrazole derivatives as potentiators of glutamate receptors |
| 09/20/2011 | CA2525470C External patch containing estrogen and/or progestogen |
| 09/20/2011 | CA2516934C Substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives |
| 09/20/2011 | CA2503868C Sulfonamides, sulfamates and sulfamides as gamma-secretase inhibitors |
| 09/20/2011 | CA2482637C New esters of hydroxy-substituted nitrogen heterocycles as antagonists of the muscarinic m3 receptor, processes for the preparation thereof as well as the use thereof as pharmaceutical compositions |
| 09/20/2011 | CA2471943C .beta.-amyloid protein production-secretion inhibitors |
| 09/20/2011 | CA2462903C Beta-lactamyl vasopressin v1a antagonists |
| 09/20/2011 | CA2461812C 3-(arylamino)methylene-1,3-dihydro-2h-indol-2-ones as kinase inhibitors |
| 09/20/2011 | CA2458210C Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as ppar-activators |
| 09/20/2011 | CA2455966C Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists |
| 09/20/2011 | CA2453817C Organophosphorus compounds for the activation of gamma/delta t-cells |
| 09/20/2011 | CA2443403C 5-membered heterocycles, preparation and use thereof as mao inhibitors and lipid peroxidation inhibitors, preparation thereof and use thereof as medicaments |
| 09/20/2011 | CA2417904C Compounds acting as melanocortin receptor ligands |
| 09/20/2011 | CA2416519C Transportation of nucleic acid substances |
| 09/20/2011 | CA2411726C Use of ingenanes in treating a pkc-related condition or disorder |
| 09/20/2011 | CA2376485C Recombinant anti-cd40 antibody and uses thereof |
| 09/15/2011 | WO2011113065A2 Pegylated polyplexes for polynucleotide delivery |
| 09/15/2011 | WO2011113048A2 Modulation of cytokine signaling |
| 09/15/2011 | WO2011112893A2 Compositions for ameliorating cell proliferative disorders and methods of making and using them |
| 09/15/2011 | WO2011112873A2 Extracorporeal immunoadsorption treatment |
| 09/15/2011 | WO2011112859A2 Methods relating to olanzapine pharmacogenetics |
| 09/15/2011 | WO2011112679A1 Synthesis of alpha-tocopherolquinone derivatives, and methods of using the same |
| 09/15/2011 | WO2011112535A2 Propionic acids, propionic acid esters, and related compounds |
| 09/15/2011 | WO2011112428A2 Arylvinylazacycloalkane compounds for constipation |
| 09/15/2011 | WO2011111875A1 N-acyl cyclic amine derivative or pharmaceutically acceptable salt thereof |
| 09/15/2011 | WO2011111714A1 Novel ep4 agonist |
| 09/15/2011 | WO2011111384A1 Transdermal composition containing therapeutic agent for parkinson's disease |
| 09/15/2011 | WO2011111355A1 Prophylactic/therapeutic agent for peripheral neuropathy comprising l-serine |
| 09/15/2011 | WO2011111039A1 Herbal composition for preventing and\or treating anxiety and related conditions |
| 09/15/2011 | WO2011110954A1 Highly pure varenicline or a pharmaceutically acceptable salt thereof substantially free of methylvarenicline impurity |
| 09/15/2011 | WO2011110613A1 Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5) |
| 09/15/2011 | WO2011110612A1 Inhibitors of protein kinases |
| 09/15/2011 | WO2011110608A1 Treatment of dementia of alzheimer's type with masitinib |
| 09/15/2011 | WO2011110595A1 Crystalline salts and/or cocrystals of o-desmethyltramadol |
| 09/15/2011 | WO2011110545A1 Imidazo [1, 2 -a] pyrazine derivatives and their use for the prevention or treatment of neurological, psychiatric and metabolic disorders and diseases |
| 09/15/2011 | WO2011110183A1 Azaisoquinolinone derivatives as nk3 antagonists |
| 09/15/2011 | WO2011071920A9 Promoting cycling of apoe4 isoform |
| 09/15/2011 | WO2011060363A3 Cyclohexyl urea modulators of d2 receptors and/or d3 receptors |
| 09/15/2011 | WO2011056788A3 Inhibiting neurotransmitter reuptake |
| 09/15/2011 | WO2011046411A3 Chestnut extracts with neuro cellular protective activity and acetylcholinesterase inhibiting activity, and use thereof |
| 09/15/2011 | WO2011041989A3 Tricyclic and tetracyclic systems with activity on the central-nervous and vascular systems |
| 09/15/2011 | WO2011006157A9 Rxr agonist compounds and methods |
| 09/15/2011 | WO2009053536A8 Splice variants of gdnf and uses thereof |
| 09/15/2011 | US20110224675 Minimally invasive treatment of vertebra (mitv) using a calcium phosphate combination bone cement |
| 09/15/2011 | US20110224304 Biphenylacetamide derivative |
| 09/15/2011 | US20110224303 Use of ci-994 and dinaline for the treatment of memory/cognition and anxiety disorders |
| 09/15/2011 | US20110224302 Difluorophenyldiacylhydrazide derivatives |
| 09/15/2011 | US20110224300 USE OF POTASSIUM 2-(a- HYDROXYPENTYL) BENZOATE IN THE MANUFACTURE OF MEDICAMENTS FOR PREVENTING AND/OR TREATING SENILE DEMENTIA |
| 09/15/2011 | US20110224294 Cinamic compounds and derivatives therefrom for the inhibition of histone deacetylase |
| 09/15/2011 | US20110224287 Augmented cognitive training |
| 09/15/2011 | US20110224285 Oligomeric compounds for the modulation of hif-1a expression |
| 09/15/2011 | US20110224283 Antisense modulation of nuclear hormone receptors |
| 09/15/2011 | US20110224278 Methods and compositions for treating a subject for central nervous system (cns) injury |
| 09/15/2011 | US20110224275 Inhibitors of matrix metalloproteinases |